BMO Capital Reiterates Outperform Rating on TrueBlue (TBI)
Tweet Send to a Friend
BMO Capital analyst Jeffrey Silber reiterated an Outperform rating and $12.00 price target on TrueBlue (NYSE: TBI).The analyst commented, "After ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
